Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The present findings raise the possibility that new effective therapies may be developed for CMT2A, which target the underlying pathophysiology.

A New Genetic Defect in Charcot-Marie-Tooth Disease Links It to Mitochondrial Dysfunction